Cargando…
Contemporary Tailored Oncology Treatment of Biliary Tract Cancers
Biliary tract cancers (BTCs) are poor prognosis malignancies with limited treatment options. Capecitabine has recently emerged as an effective agent in the adjuvant setting; however, treatment of advanced disease is still limited to first-line cisplatin and gemcitabine chemotherapy. Recent global ef...
Autores principales: | Turkes, Fiona, Carmichael, Juliet, Cunningham, David, Starling, Naureen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935796/ https://www.ncbi.nlm.nih.gov/pubmed/31929787 http://dx.doi.org/10.1155/2019/7698786 |
Ejemplares similares
-
Targeting the immune milieu in gastrointestinal cancers
por: Turkes, Fiona, et al.
Publicado: (2020) -
Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma
por: Fong, Caroline Y. K., et al.
Publicado: (2019) -
Precision Oncology Targets in Biliary Tract Cancer
por: Farha, Nicole, et al.
Publicado: (2023) -
Role of erlotinib in the management of pancreatic cancer
por: Starling, Naureen, et al.
Publicado: (2006) -
Adjuvant treatment in biliary tract cancer
por: Palloni, Andrea, et al.
Publicado: (2019)